ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Novartis Pharmaceuticals · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
cardiovascular-disease
atherosclerotic cardiovascular disease (ascvd), lipoprotein(a), cardiovascular disease, ascvd, pelacarsen (tqj230), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 853699
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.